Related Experiment Video
Updated: May 10, 2026

Cell Type-specific Gene Expression Profiling in the Mouse Liver
Published on: September 17, 2019
Genome-wide transcriptome analysis identifies novel gene signatures implicated in human chronic liver disease
Rana V Smalling1, Don A Delker, Yuxia Zhang
1Dept. of Medicine and Huntsman Cancer Institute, Univ. of Utah School of Medicine, Salt Lake City, Utah, 84132. l.wang@hsc.utah.edu.
Abstract:
The molecular mechanisms behind human liver disease progression to cirrhosis remain elusive. Nuclear receptor small heterodimer partner (SHP/Nr0b2) is a hepatic tumor suppressor and a critical regulator of liver function. SHP expression is diminished in human cirrhotic livers, suggesting a regulatory role in human liver diseases. The goal of this study was to identify novel SHP-regulated genes that are involved in the development and progression of chronic liver disease. To achieve this, we conducted the first comprehensive RNA sequencing (RNA-seq) analysis of Shp(-/-) mice, compared the results with human hepatitis C cirrhosis RNA-seq and nonalcoholic steatohepatitis (NASH) microarray datasets, and verified novel results in human liver biospecimens. This approach revealed new gene signatures associated with chronic liver disease and regulated by SHP. Several genes were selected for validation of physiological relevance based on their marked upregulation, novelty with regard to liver function, and involvement in gene pathways related to liver disease. These genes include peptidoglycan recognition protein 2, dual specific phosphatase-4, tetraspanin 4, thrombospondin 1, and SPARC-related modular calcium binding protein-2, which were validated by qPCR analysis of 126 human liver specimens, including steatosis, fibrosis, and NASH, alcohol and hepatitis C cirrhosis, and in mouse models of liver inflammation and injury. This RNA-seq analysis identifies new genes that are regulated by the nuclear receptor SHP and implicated in the molecular pathogenesis of human chronic liver diseases. The results provide valuable transcriptome information for characterizing mechanisms of these diseases.
Insights
This study identifies novel genes regulated by small heterodimer partner (SHP) involved in chronic liver disease progression. These findings offer new insights into the molecular mechanisms of liver diseases like cirrhosis and nonalcoholic steatohepatitis.
Area of Science:
- Hepatology and Molecular Biology
- Genomics and Transcriptomics
- Nuclear Receptor Signaling
Background:
- The progression of human liver disease to cirrhosis involves complex molecular mechanisms that are not fully understood.
- Small heterodimer partner (SHP/Nr0b2), a nuclear receptor, acts as a hepatic tumor suppressor, and its reduced expression in cirrhotic livers suggests a role in disease pathogenesis.
- Identifying SHP-regulated genes is crucial for understanding chronic liver disease development.
Purpose of the Study:
- To identify novel genes regulated by SHP that contribute to the development and progression of chronic liver disease.
- To elucidate the molecular pathways influenced by SHP in liver disease pathogenesis.
- To provide a comprehensive transcriptomic profile of SHP-deficient livers in the context of liver disease.
Main Methods:
- Comprehensive RNA sequencing (RNA-seq) analysis of Shp(-/-) mice.
- Comparison of mouse RNA-seq data with human hepatitis C cirrhosis RNA-seq and nonalcoholic steatohepatitis (NASH) microarray datasets.
- Validation of identified genes in 126 human liver specimens and mouse models of liver injury using quantitative PCR (qPCR).
Main Results:
- Discovery of new gene signatures associated with chronic liver disease and regulated by SHP.
- Identification of several key genes, including peptidoglycan recognition protein 2, dual specific phosphatase-4, tetraspanin 4, thrombospondin 1, and SPARC-related modular calcium binding protein-2, upregulated in liver disease.
- Validation of these genes' physiological relevance across various human liver conditions (steatosis, fibrosis, NASH, cirrhosis) and mouse models.
Conclusions:
- This study identifies novel SHP-regulated genes implicated in the molecular pathogenesis of human chronic liver diseases.
- The findings provide valuable transcriptome information for characterizing the mechanisms underlying liver disease progression.
- The identified genes represent potential targets for future therapeutic strategies in liver disease management.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Cell Specific Gene Expression